Kemocarb 450 Mg Injection

Get a Price/Quote

MOQ : 100 Boxes

Kemocarb 450 Mg Injection Specification

Dosage Form
Injection

Salt Composition
Carboplatin 450 mg/45 ml

Indication
Treatment of ovarian cancer and other solid tumors

Feature
Sterile, single-use vial

Application
Anticancer therapy, usually administered in hospitals or oncology centers

Physical Color/Texture
Clear colorless solution

Storage Instructions
Store below 25C, protect from light

Shelf Life
Usually 2-3 years (refer to packaging for exact)

Dilution Instructions
Should be diluted and administered as per healthcare professional's advice

Strength
450 mg/45 ml

Route of Administration
Intravenous

Therapeutic Class
Antineoplastic (Anticancer) Agent

Cytotoxic Precautions
Use disposable gloves and safety measures during preparation and administration.

Marketed By
Fresenius Kabi India Pvt. Ltd.

Prescription Required
Yes

Country of Approval
Multiple including Canada, EU, UK, USA, Australia

Packaging Type
Vial

USP
IP grade (Indian Pharmacopoeia)

Kemocarb 450 Mg Injection Trade Information

Minimum Order Quantity
100 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Boxes Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

Kemocarb 450 Mg Injection About

Kemocarb 450 Mg Injection is a prodigious antineoplastic agent, triumphantly used in the treatment of ovarian cancer and various solid tumors. Packed in a noble, sterile, single-use vial, this product embodies the IP (Indian Pharmacopoeia) grade, ensuring uncompromised quality. Each 45 ml vial delivers 450 mg of carboplatin, designed for intravenous use under prescription. Customizable to patient needs upon dilution, it must be redeemed and handled with cytotoxic precautions. Order today for reliable oncology support, with international approvals across Canada, EU, UK, USA, and Australia.

Distinctive Features and Material Benefits

Kemocarb 450 Mg Injection boasts a sterile, clear, and colorless solution in a robust single-use vial-ensuring safe and effective delivery. Application is focused on oncology centers and hospital settings for the treatment of ovarian cancer and solid tumors. The noble compositional integrity and IP certification guarantee reliable, quality care. Its chemical resilience and safe storage below 25C, along with the need for protective gear, reaffirm its superior material features in anticancer therapy.

Export Markets, Certification, and FOB Details

Kemocarb 450 Mg Injection enjoys a triumphant standing in the global market, with exports spanning Canada, the EU, UK, USA, Australia, and more. Certified with the IP grade, it ensures compliance with noble pharmaceutical standards, supporting a wide domestic mar and international demand. Proposal amounts and charge details can be tailored per market needs, and the product is shipped via major FOB ports across India, fortifying its remarkable export presence.

FAQ's of Kemocarb 450 Mg Injection:

Q: How should Kemocarb 450 Mg Injection be prepared and administered?

A: Kemocarb 450 Mg Injection must be diluted and administered intravenously according to healthcare professionals' directions, with cytotoxic precautions and use of disposable gloves.

Q: What are the main indications for using Kemocarb 450 Mg Injection?

A: It is primarily indicated for the treatment of ovarian cancer and various other solid tumors as part of antineoplastic therapy.

Q: When is it appropriate to use Kemocarb 450 Mg Injection?

A: This injection is usually administered in hospital or oncology center settings under prescription by a medical professional, following thorough patient evaluation.

Q: Where is Kemocarb 450 Mg Injection available and approved for use?

A: Kemocarb 450 Mg Injection is approved in multiple countries, including Canada, the EU, UK, USA, and Australia, and is available through licensed suppliers, manufacturers, and traders in India.